Attention-deficit/hyperactivity disorder (ADHD) is highly heritable, and clinicians frequently encounter young children with ADHD whose parents also have ADHD symptoms that interfere with attending treatment, remembering behavioral plans, and practicing new skills consistently. Behavioral parent training (BPT) is evidence-based but may be less effective when the parent has ADHD, and treating parental ADHD alone hasn't reliably improved parenting or child outcomes. This trial tested whether treating both problems in sequence helps.

Study Design
The TPAC study, a Type I hybrid effectiveness-implementation randomized trial (2020-2025), enrolled 120 parents with DSM-5 ADHD and their 3- to 8-year-old, stimulant-naive children with at least moderate clinical severity. The sample included 25% fathers and 27% Black/African-American parents. Families were randomized equally to integrated behavioral parent training (I-BPT) alone or to parent stimulant medication titration followed by the same I-BPT program. I-BPT combined standard parenting strategies (routines, praise, effective commands, emotion coaching, etc.) with cognitive-behavioral and organizational skills targeting the parent's own ADHD, delivered over 10-11 telehealth sessions. In the combined arm, extended-release mixed amphetamine salts were first-line, titrated for response and tolerability; 85% of medicated parents achieved an optimal response. The prespecified primary outcome was child Clinical Global Impressions-Severity (CGI-S), rated by masked evaluators at baseline and weeks 8, 16, and 36.

Key Findings
Engagement was similar across groups (mean 8.8 I-BPT sessions; ~77% completed 9+). Child CGI-S declined significantly faster when parents received stimulant treatment before I-BPT (d = 0.37, p = .001; week-16 means 3.78 vs. 4.04). Child global improvement also favored combined treatment (d = 0.38) — notably, children remained stimulant-naive throughout, so this benefit followed treatment directed at the parent. Parents who received medication before I-BPT also improved faster on their own global severity (d = 0.33) and improvement (d = 0.37), with small gains in positive parenting (d = 0.24) and reduced inconsistent discipline (d = 0.22). Punitive parenting and observed positive/negative parenting improved similarly in both arms — medication added benefit for select parenting behaviors rather than driving all parenting improvement.

CGI-S = Clinical Global Impressions-Severity; I-BPT = integrated behavioral parent training. Punitive parenting and observed positive/negative parenting improved similarly in both arms and are not shown.

These findings support a family-systems approach: asking whether a caregiver has untreated ADHD may reveal a modifiable barrier to treatment follow-through, and adult ADHD treatment could be considered as an adjunct — not a replacement — for direct child treatment. Since attendance didn't differ between groups, medication's benefit likely isn't just about getting parents to more sessions, though better at-home implementation remains untested.

Limitations: Enrollment was reduced from a planned 240 to 120 dyads due to a site closure; the sample was relatively advantaged (70% bachelor's+, median income $140,000); only medication-willing families were included; the primary outcome was a global rating rather than domain-specific symptoms; CGI interrater reliability wasn't formally assessed; and the medication phase was open-label. Effect sizes were modest, arguing for calibrated expectations rather than a universal sequencing rule.

Bottom line: In families where both parent and child have ADHD, treating the parent's ADHD before I-BPT produced faster, small-to-moderate improvements in parent and child clinical severity and modest gains in parenting consistency and positivity. I-BPT itself improved several parenting behaviors regardless of medication — for clinicians, the takeaway is to assess the caregiving context and consider treating parental ADHD as part of effective childhood ADHD care.

Reference:

Chronis-Tuscano A, Bounoua N, Danko CM, et al. J Child Psychol Psychiatry. 2026. doi:10.1111/jcpp.70222